Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/45927
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFADLALLAH, sukayna-
dc.contributor.authorVANDORMAEL, Patrick-
dc.contributor.authorRUYTINX, Pieter-
dc.contributor.authorPUES, Astrid-
dc.contributor.authorSLEURS, Ellen-
dc.contributor.authorLIESENBORGS, Jori-
dc.contributor.authorJoly, J.-
dc.contributor.authorAGTEN, Anouk-
dc.contributor.authorVANDENABEELE, Frank-
dc.contributor.authorFRAUSSEN, Judith-
dc.contributor.authorVERSCHUEREN, Pieter-
dc.contributor.authorSOMERS, Veerle-
dc.date.accessioned2025-05-09T06:55:22Z-
dc.date.available2025-05-09T06:55:22Z-
dc.date.issued2024-
dc.date.submitted2025-04-18T11:00:18Z-
dc.identifier.citationAnnals of the rheumatic diseases, 83 (Art N° POS0723)-
dc.identifier.urihttp://hdl.handle.net/1942/45927-
dc.language.isoen-
dc.publisherELSEVIER-
dc.subject.otherBiomarkers-
dc.subject.otherDisease-modifying Drugs (DMARDs)-
dc.subject.otherAutoantibodies-
dc.subject.otherFibroblasts-
dc.titleThe predictive potential of novel antibody biomarkers in determining first-line therapy response in rheumatoid arthritis-
dc.typeJournal Contribution-
dc.identifier.volume83-
local.format.pages2-
local.bibliographicCitation.jcatM-
local.publisher.placeRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
local.bibliographicCitation.artnrPOS0723-
dc.identifier.doi10.1136/annrheumdis-2024-eular.2982-
dc.identifier.isi001461663400050-
local.provider.typewosris-
local.description.affiliation[Fadlallah, S.; Vandormael, P.; Ruytinx, P.; Pues, A.; Sleurs, E.; Fraussen, J.; Somers, V.] Hasselt Univ, Dept Immunol & Infect, Hasselt, Belgium.-
local.description.affiliation[Liesenborgs, J.] Hasselt Univ, Expertise Ctr Digital Media, Hasselt, Belgium.-
local.description.affiliation[Joly, J.] Univ Hosp Leuven, Div Rheumatol, Leuven, Belgium.-
local.description.affiliation[Agten, A.; Vandenabeele, F.] Hasselt Univ, REVAL Rehabil Res Ctr, Hasselt, Belgium.-
local.description.affiliation[Verschueren, P.] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium.-
local.uhasselt.internationalno-
item.contributorFADLALLAH, sukayna-
item.contributorVANDORMAEL, Patrick-
item.contributorRUYTINX, Pieter-
item.contributorPUES, Astrid-
item.contributorSLEURS, Ellen-
item.contributorLIESENBORGS, Jori-
item.contributorJoly, J.-
item.contributorAGTEN, Anouk-
item.contributorVANDENABEELE, Frank-
item.contributorFRAUSSEN, Judith-
item.contributorVERSCHUEREN, Pieter-
item.contributorSOMERS, Veerle-
item.fullcitationFADLALLAH, sukayna; VANDORMAEL, Patrick; RUYTINX, Pieter; PUES, Astrid; SLEURS, Ellen; LIESENBORGS, Jori; Joly, J.; AGTEN, Anouk; VANDENABEELE, Frank; FRAUSSEN, Judith; VERSCHUEREN, Pieter & SOMERS, Veerle (2024) The predictive potential of novel antibody biomarkers in determining first-line therapy response in rheumatoid arthritis. In: Annals of the rheumatic diseases, 83 (Art N° POS0723).-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
crisitem.journal.issn0003-4967-
crisitem.journal.eissn1468-2060-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
POS0723 THE PREDICTIVE POTENTIAL OF NOVEL ANTIBODY BIOMARKERS IN DETERMINING FIRST.pdf
  Restricted Access		Supplementary material56.35 kBAdobe PDFView/Open    Request a copy
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.